Kewaunee Scientific Corporation
KEQU
$41.53
-$1.61-3.73%
NASDAQ
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -7.83% | 14.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.83% | 14.86% | |||
| Cost of Revenue | -5.53% | 8.86% | |||
| Gross Profit | -12.93% | 30.79% | |||
| SG&A Expenses | 3.75% | -3.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.43% | 5.75% | |||
| Operating Income | -43.41% | 277.78% | |||
| Income Before Tax | -45.17% | 460.71% | |||
| Income Tax Expenses | -65.44% | 2,138.89% | |||
| Earnings from Continuing Operations | -36.14% | 257.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 31.96% | -234.48% | |||
| Net Income | -36.23% | 258.20% | |||
| EBIT | -43.41% | 277.78% | |||
| EBITDA | -35.09% | 156.91% | |||
| EPS Basic | -36.16% | 260.50% | |||
| Normalized Basic EPS | -45.40% | 472.77% | |||
| EPS Diluted | -36.15% | 261.98% | |||
| Normalized Diluted EPS | -45.13% | 471.88% | |||
| Average Basic Shares Outstanding | -0.11% | -0.63% | |||
| Average Diluted Shares Outstanding | -0.60% | -0.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||